ZEPHYR AI
Zephyr AI is a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery and precision medicine. Zephyr AI collaborates with top health systems, health insurance plans, and biotechnology innovators to enhance Quality, Outcomes, and Costs.
ZEPHYR AI
Industry:
Artificial Intelligence (AI) Biotechnology Medical
Founded:
2020-01-01
Address:
Fairfax Station, Virginia, United States
Country:
United States
Website Url:
http://www.zephyrai.bio
Total Employee:
11+
Status:
Active
Total Funding:
129.5 M USD
Technology used in webpage:
Domain Not Resolving HSTS ReCAPTCHA ReCAPTCHA V2 Amazon CloudFront Amazon Cognito Cloudflare Radar AWS Cloudfront Taipei TW Edge Cloudflare Radar Top 500k AWS Cloudfront Manila Edge
Similar Organizations
MapLight Therapeutics
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
OM1
OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Employees Featured
Founder
Investors List
Eli Lilly & Company Foundation
Eli Lilly & Company Foundation investment in Series A - Zephyr AI
Revolution Growth
Revolution Growth investment in Series A - Zephyr AI
Jeff Skoll
Jeff Skoll investment in Series A - Zephyr AI
EPIQ Capital Group
EPIQ Capital Group investment in Series A - Zephyr AI
Allen Chao
Allen Chao investment in Seed Round - Zephyr AI
BoxGroup
BoxGroup investment in Seed Round - Zephyr AI
Lerner Enterprises
Lerner Enterprises investment in Seed Round - Zephyr AI
Liquid 2 Ventures
Liquid 2 Ventures investment in Seed Round - Zephyr AI
AME Cloud Ventures
AME Cloud Ventures investment in Seed Round - Zephyr AI
MedStar Health
MedStar Health investment in Seed Round - Zephyr AI
Key Employee Changes
| Date | New article |
|---|---|
| 2024-04-02 | Rachael Brake, PhD, Joins Zephyr AI as Chief Scientific Officer |
| 2023-06-05 | Experienced Biotech Executive and Deal Maker Joins Zephyr AI as Chief Business Officer |
Official Site Inspections
http://www.zephyrai.bio Semrush global rank: 6.25 M Semrush visits lastest month: 1.07 K
- Host name: ec2-44-210-60-33.compute-1.amazonaws.com
- IP address: 44.210.60.33
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Zephyr AI"
Zephyr AI
I believe the team today is uniquely positioned to transform the way the biopharmaceutical industry approaches drug discovery, development, and precision analytics.See details»
Zephyr AI - Crunchbase Company Profile & Funding
Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.See details»
Zephyr AI
Work at Zephyr AI We are a multidisciplinary team of world-class software engineers, scientists, and entrepreneurs dedicated to leveraging big data and cutting-edge technology to derive …See details»
Zephyr AI Company Profile | Management and Employees List
Zephyr AI Profile and History Zephyr AI is a high-growth healthcare technology company committed to radically reshaping precision medicine in oncology and cardiometabolic disease. …See details»
Zephyr AI - LinkedIn
Zephyr AI | 4,927 followers on LinkedIn. Harnessing Real World Data to Transform Precision Medicine | Zephyr AI uses large complex data and proprietary algorithms to discover new insights and ...See details»
Zephyr AI - VentureRadar
Private Company Leverages artificial intelligence to improve patient care and medical research, focusing on oncology and cardiometabolic diseases, and aims to democratize precision medicine.See details»
Zephyr AI Company Profile - Office Locations, Competitors ... - Craft
Zephyr AI has 5 employees at their 1 location and $18.5 m in total funding,. See insights on Zephyr AI including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Zephyr AI 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Zephyr AI. Use the PitchBook Platform to explore the full profile.See details»
From data ingestion to production in less than 30 days: …
Moving from data ingestion to production in a month, allowing Zephyr to quickly create more precise models that predict optimal therapies for various disease states — leading to better outcomes and lower costsSee details»
Zephyr AI Raises $18.5 Million in Seed Funding Led by …
Mar 30, 2022 Visit us at zephyrai.bio and follow us on Twitter, Instagram and LinkedIn. About Red Cell Partners Red Cell Partners is an investment and incubation firm that backs, builds, and scales technology-led companies …See details»
Zephyr AI - Company info. interviews, news - BiopharmaTrend
Zephyr AI is a high-growth healthcare technology company committed to radically rebuilding drug discovery and precision medicine from the ground up. By harnessing the power of next …See details»
Zephyr AI
Zephyr AI Presents the Development of a Novel AI-Enabled Composite Biomarker Effective in Predicting Sensitivity to PARP Inhibition in Late-line Cancer PatientsSee details»
Zephyr AI - Overview, News & Similar companies | ZoomInfo.com
View Zephyr AI (zephyrai.bio) location in Virginia, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»
Experienced Biotech Executive and Deal Maker Joins Zephyr AI as …
Jun 5, 2023 Visit us at www.zephyrai.bio and follow us on Twitter, Instagram, and LinkedIn .See details»
Zephyr Venture Capital and Private Equity Financings
Zephyr AI is a high-growth healthcare technology company committed to radically reshaping precision medicine in oncology and cardiometabolic disease. Through partnerships and …See details»
Zephyr AI
While our foundational models generate novel drug-specific signatures and corresponding biological rationales that validate in complex Real World Data cohorts, it is sometimes …See details»
Zephyr AI Raises $18.5 Million in Seed Funding Led by Lerner and …
Mar 30, 2022 Visit us at zephyrai.bio and follow us on Twitter, Instagram and LinkedIn. About Red Cell PartnersSee details»
Zephyr AI · GitHub
People This organization has no public members. You must be a member to see who’s a part of this organization.See details»
BIO Statement on Resignation of Peter Marks from the FDA
2 days ago John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the …See details»
Zephyr AI
Jun 4, 2024 A systems biology-informed machine learning framework to predict drug response using clinically available NGS data.See details»